Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status / Alimena, G; Breccia, M; Mancini, M; Diverio, D; Nanni, M; DE PROPRIS, Ms; Cimino, G; Pane, Fabrizio; Mandelli, F.. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 19:2(2005), pp. 287-289. [10.1038/sj.leu.2403683]
Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status.
PANE, FABRIZIO;
2005
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
